Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir
NCT06000657
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
196
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B, Chronic
Interventions
DRUG:
Vemliver tablet
DRUG:
Baracross Tablet
Sponsor
Daewoong Pharmaceutical Co. LTD.